Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered From an Episcleral Reservoir for Treatment of Macular Edema Secondary to Diabetes and Other Causes

NCT04005430 is registered in ClinicalTrials.gov with Targeted Therapy Technologies, LLC as lead sponsor.

NCT NCT04005430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered From an Episcleral Reservoir for Treatment of Macular Edema Secondary to Diabetes and Other Causes
Lead sponsor
Targeted Therapy Technologies, LLC
Phase
Phase 1
Overall status
Unknown status
Start date
April 3, 2019
Completion date
September 30, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory diabetic macular edema